Discover Kymera Therapeutics' Q3 2025 earnings, clinical trial milestones in immunology, and strategic Gilead partnership.

Identity resolution often anchors vendor pitches. Vendors claim CDPs can merge disparate identifiers into coherent customer ...

Lithium Ionic Corp has filed an NI 43-101 compliant technical report for its Bandeira Lithium Project in Brazil, marking a significant step in its development. The report, prepared by experienced ...

On-chain analysts can’t stop a crash, but by tracking capital movement, leverage, and sentiment, they can spot the storm ...

Garg, recently named to BioSpace’s 40 Under 40, proved her mettle managing one of the toughest partnerships out there: the ...

New research reveals that men need twice as much exercise as women to prevent heart disease. The study shows that women ...

With IAB lowering the 2025 U.S. ad spend outlook from 7.3% to 5.7%, it is evident that ad budgets have come under significant pressure. Amid the slowdown, competition from walled gardens such as ...

Microsoft CEO Satya Nadella and his team are expected to discuss Copilot, Azure, AI, cloud, security and other topics on the ...

The company intends to meet with the FDA to discuss results that showed a level of improvement on a marker of muscle stability that one executive described as a “home run.” BridgeBio’s market value ...

While research has long held the far right to be the most persistent domestic terror threat, a controversial new report ...

XRP price chart inconsistencies spark concern as analysts abandon data from top exchanges over distortions. EGRAG Crypto now uses a unified Crypto Data Set for XRP to avoid conflicting market price ...